EASTMAN CHEMICAL CO (EMN) Current Ratio
- Current ratio · latest quarter: Value 1.50×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.50× | Current assets / current liabilities. $4.25B ÷ $2.84B ≈ 1.50× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 4.25B USD | Assets, Current |
| Current obligations | 2.84B USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 1.10B USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 2.10B USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.25B | $2.84B | (m) | (m) | $1.10B | $2.10B | (m) | (m) | 1.50× |
| 2026-03-31 | $4.06B | $2.77B | (m) | (m) | $949.00M | $2.08B | (m) | (m) | 1.47× |
| 2025-12-31 | $3.65B | $2.65B | (m) | (m) | $737.00M | $1.98B | (m) | (m) | 1.37× |
| 2025-09-30 | $3.79B | $2.16B | (m) | (m) | $933.00M | $1.94B | (m) | (m) | 1.76× |
| 2025-06-30 | $4.02B | $2.39B | (m) | (m) | $988.00M | $2.15B | (m) | (m) | 1.68× |
| 2025-03-31 | $3.90B | $2.27B | (m) | (m) | $894.00M | $2.12B | (m) | (m) | 1.72× |
| 2024-12-31 | $4.10B | $2.71B | $837.00M | (m) | $791.00M | $1.99B | (m) | (m) | 1.51× |
| 2024-09-30 | $3.94B | $2.59B | (m) | (m) | $980.00M | $1.90B | (m) | (m) | 1.52× |
| 2024-06-30 | $3.84B | $2.74B | (m) | (m) | $957.00M | $1.90B | (m) | (m) | 1.40× |
| 2024-03-31 | $3.64B | $2.62B | (m) | (m) | $926.00M | $1.77B | (m) | (m) | 1.39× |
| 2023-12-31 | $3.48B | $2.58B | $548.00M | (m) | $826.00M | $1.68B | (m) | (m) | 1.35× |
| 2023-09-30 | $3.57B | $2.62B | (m) | (m) | $880.00M | $1.72B | (m) | (m) | 1.36× |
| 2023-06-30 | $3.67B | $2.79B | (m) | (m) | $923.00M | $1.96B | (m) | (m) | 1.32× |
| 2023-03-31 | $3.97B | $2.97B | (m) | (m) | $1.05B | $1.94B | (m) | (m) | 1.34× |
| 2022-12-31 | $3.78B | $3.25B | $493.00M | (m) | $957.00M | $1.89B | (m) | (m) | 1.16× |
| 2022-09-30 | $4.11B | $3.21B | (m) | (m) | $1.14B | $1.98B | (m) | (m) | 1.28× |
| 2022-06-30 | $4.00B | $3.15B | (m) | (m) | $1.21B | $1.83B | (m) | (m) | 1.27× |
| 2022-03-31 | $4.93B | $3.14B | $487.00M | (m) | $1.19B | $1.67B | (m) | (m) | 1.57× |
| 2021-12-31 | $4.65B | $2.97B | $459.00M | (m) | $1.09B | $1.50B | (m) | (m) | 1.56× |
| 2021-09-30 | $4.88B | $3.11B | $717.00M | (m) | $1.36B | $1.63B | (m) | (m) | 1.57× |
| 2021-06-30 | $4.74B | $2.29B | $609.00M | (m) | $1.29B | $1.50B | (m) | (m) | 2.06× |
| 2021-03-31 | $3.80B | $2.02B | $540.00M | (m) | $1.23B | $1.50B | (m) | (m) | 1.88× |
| 2020-12-31 | $3.54B | $2.04B | $564.00M | (m) | $1.03B | $1.38B | (m) | (m) | 1.74× |
| 2020-09-30 | $3.53B | $1.79B | $650.00M | (m) | $1.08B | $1.34B | (m) | (m) | 1.98× |
| 2020-06-30 | $3.53B | $1.88B | $704.00M | (m) | $904.00M | $1.42B | (m) | (m) | 1.88× |
| 2020-03-31 | $3.85B | $2.31B | $680.00M | (m) | $1.04B | $1.66B | (m) | (m) | 1.66× |
| 2019-12-31 | $3.32B | $1.79B | $204.00M | (m) | $980.00M | $1.66B | (m) | (m) | 1.86× |
| 2019-09-30 | $3.44B | $2.08B | $207.00M | (m) | $1.19B | $1.70B | (m) | (m) | 1.65× |
| 2019-06-30 | $3.52B | $2.23B | $186.00M | (m) | $1.23B | $1.73B | (m) | (m) | 1.58× |
| 2019-03-31 | $3.55B | $2.35B | $195.00M | (m) | $1.30B | $1.70B | (m) | (m) | 1.51× |
| 2018-12-31 | $3.37B | $1.85B | $226.00M | (m) | $1.15B | $1.58B | (m) | (m) | 1.82× |
| 2018-09-30 | $3.65B | $2.15B | $193.00M | (m) | $1.40B | $1.63B | (m) | (m) | 1.69× |
| 2018-06-30 | $3.50B | $2.07B | $193.00M | (m) | $1.39B | $1.53B | (m) | (m) | 1.69× |
| 2018-03-31 | $3.48B | $2.03B | $194.00M | (m) | $1.43B | $1.48B | (m) | (m) | 1.72× |
| 2017-12-31 | $3.14B | $1.98B | $191.00M | (m) | $1.03B | $1.51B | (m) | (m) | 1.59× |
| 2017-09-30 | $3.25B | $1.77B | $195.00M | (m) | $1.05B | $1.58B | (m) | (m) | 1.83× |
| 2017-06-30 | $3.26B | $1.60B | $222.00M | (m) | $1.02B | $1.54B | (m) | (m) | 2.04× |
| 2017-03-31 | $3.17B | $1.64B | $197.00M | (m) | $982.00M | $1.50B | (m) | (m) | 1.93× |
| 2016-12-31 | $2.87B | $1.79B | $181.00M | (m) | $812.00M | $1.40B | (m) | (m) | 1.60× |
| 2016-09-30 | $2.90B | $2.21B | $207.00M | (m) | $905.00M | $1.47B | (m) | (m) | 1.31× |
| 2016-06-30 | $2.93B | $2.19B | $240.00M | (m) | $951.00M | $1.45B | (m) | (m) | 1.34× |
| 2016-03-31 | $2.86B | $1.85B | $202.00M | (m) | $951.00M | $1.49B | (m) | (m) | 1.55× |
| 2015-12-31 | $2.88B | $2.06B | $293.00M | (m) | $792.00M | $1.48B | (m) | (m) | 1.40× |
| 2015-09-30 | $3.18B | $1.80B | $309.00M | (m) | $968.00M | $1.48B | (m) | (m) | 1.77× |
| 2015-06-30 | $3.17B | $1.82B | $268.00M | (m) | $1.02B | $1.44B | (m) | (m) | 1.74× |
| 2015-03-31 | $3.17B | $1.76B | $196.00M | (m) | $998.00M | $1.45B | (m) | (m) | 1.79× |
| 2014-12-31 | $3.17B | $2.02B | $214.00M | (m) | $936.00M | $1.51B | (m) | (m) | 1.57× |
| 2014-09-30 | $2.89B | $1.40B | $212.00M | (m) | $985.00M | $1.36B | (m) | (m) | 2.07× |
| 2014-06-30 | $2.99B | $1.27B | $175.00M | (m) | $1.07B | $1.35B | (m) | (m) | 2.34× |
| 2014-03-31 | $2.95B | $1.26B | $185.00M | (m) | $998.00M | $1.38B | (m) | (m) | 2.34× |
| 2013-12-31 | $2.84B | $1.47B | $237.00M | (m) | $880.00M | $1.26B | (m) | (m) | 1.93× |
| 2013-09-30 | $2.77B | $1.32B | $222.00M | (m) | $967.00M | $1.27B | (m) | (m) | 2.09× |
| 2013-06-30 | $2.84B | $1.31B | $234.00M | (m) | $1.05B | $1.29B | (m) | (m) | 2.17× |
| 2013-03-31 | $2.74B | $1.29B | $178.00M | (m) | $990.00M | $1.30B | (m) | (m) | 2.12× |
| 2012-12-31 | $2.70B | $1.36B | $249.00M | (m) | $846.00M | $1.26B | (m) | (m) | 1.98× |
| 2012-09-30 | $2.67B | $1.46B | $237.00M | (m) | $954.00M | $1.27B | (m) | (m) | 1.83× |
| 2012-06-30 | $4.63B | $899.00M | $3.00B | (m) | $732.00M | $775.00M | (m) | (m) | 5.15× |
| 2012-03-31 | $2.26B | $997.00M | $569.00M | (m) | $740.00M | $768.00M | (m) | (m) | 2.27× |
| 2011-12-31 | $2.30B | $1.11B | $577.00M | (m) | $632.00M | $779.00M | (m) | (m) | 2.07× |
| 2011-09-30 | $2.35B | $1.20B | $448.00M | (m) | $711.00M | $850.00M | (m) | (m) | 1.96× |
| 2011-06-30 | $2.51B | $1.19B | $634.00M | (m) | $769.00M | $748.00M | (m) | (m) | 2.10× |
| 2011-03-31 | $2.43B | $1.05B | $640.00M | (m) | $777.00M | $675.00M | (m) | (m) | 2.31× |
| 2010-12-31 | $2.05B | $1.07B | $516.00M | (m) | $545.00M | $608.00M | (m) | (m) | 1.91× |
| 2010-09-30 | $2.10B | $940.00M | $642.00M | (m) | $701.00M | $652.00M | (m) | (m) | 2.24× |
| 2010-06-30 | $1.91B | $886.00M | $435.00M | (m) | $721.00M | $635.00M | (m) | (m) | 2.15× |
| 2010-03-31 | $1.88B | $870.00M | $483.00M | (m) | $687.00M | $588.00M | (m) | (m) | 2.16× |
| 2009-12-31 | $1.74B | $800.00M | $793.00M | (m) | $277.00M | $531.00M | (m) | (m) | 2.17× |
| 2009-09-30 | $1.58B | $828.00M | $668.00M | (m) | $316.00M | $495.00M | (m) | (m) | 1.91× |
| 2009-06-30 | $1.41B | $717.00M | $450.00M | (m) | $328.00M | $443.00M | (m) | (m) | 1.96× |
| 2008-12-31 | $1.42B | $832.00M | $387.00M | (m) | $275.00M | $637.00M | (m) | (m) | 1.71× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HEXCEL CORP /DE/ (HXL) | United States | $6.464B | 49.18 |
| AVIENT CORP (AVNT) | United States | $3.739B | 19.95 |
| ROGERS CORP (ROG) | United States | $2.435B | -34.15 |
| ALBEMARLE CORP (ALB) | United States | $12.778B | 71.05 |
| PureCycle Technologies, Inc. (PCT) | United States | $0.975B | -7.32 |
| AdvanSix Inc. (ASIX) | United States | $0.426B | -30.25 |
| DuPont de Nemours, Inc. (DD) | United States | $17.580B | 1,010.90 |
| DOW INC. (DOW) | United States | $20.577B | -11.55 |